BHC

Bausch Health Companies Stock Analysis

AI Rating

Neutral
  • Quality4/10
  • Growth↓ 1/10
  • Value↓ 3/10
Bausch Health Companies sales and earnings growth
BHC Growth
Low
  • Revenue Y/Y↑ 7.45%
  • EPS Y/Y↓ -2854.55%
  • FCF Y/Y↓ -18.67%
Bausch Health Companies gross and profit margin trends
BHC Profitability
Good
  • Gross margin ↑ 71.00%
  • EPS margin↓ -11.50%
  • ROIC 5Y↓ 5.29%
Bausch Health Companies net debt vs free cash flow
BHC Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↑ 19.7
  • Interest coverage↓ 0.5

Bausch Health Companies stock volatility is in-line with the overall market. We give it a Great risk rating.

↗ More Drug Manufacturers - Specialty & Generic stocks